Kai Cao

Dec 24, 2024 | academicradiology.org | Huanhuan Kang |Xu Bai |Chaobo Li |Sicheng Yi |Xiaohui Ding |Hao Sun | +7 more

AbbreviationsPRNRP (papillary renal neoplasm with reverse polarity)PRCC (papillary renal cell carcinoma)MRI (magnetic resonance imaging)CT (computed tomography)Key WordsPapillary renal neoplasm with reverse polarityKidney neoplasmsRenal cell carcinomaComputed tomographyMagnetic resonance imagingGet full text accessLog in, subscribe or purchase for full access. REFERENCES1. Chang, H.Y. ∙ Hang, J.F. ∙ Wu, C.Y. ...

Sep 10, 2024 | frontiersin.org | Xiaohui Yang |Kai Cao |Jie Hao |Mayinuer Yusufu

As the landscape of vision-threatening diseases continues to evolve with changing lifestyles and population aging, we must adapt our responses and strategies...

Jul 2, 2024 | onlinelibrary.wiley.com | Ying An |Kai Cao |Qi Lu |Ya-Mei Guan

DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.

Jan 18, 2024 | nature.com | Hind Rafei |May Daher |Vakul Mohanty |Merve Dede |Peter F Thall |Roland Bassett | +6 more

AbstractThere is a pressing need for allogeneic chimeric antigen receptor (CAR)-immune cell therapies that are safe, effective and affordable. We conducted a phase 1/2 trial of cord blood-derived natural killer (NK) cells expressing anti-CD19 chimeric antigen receptor and interleukin-15 (CAR19/IL-15) in 37 patients with CD19+ B cell malignancies. The primary objectives were safety and efficacy, defined as day 30 overall response (OR).

Sep 15, 2023 | researchgate.net | Tantan Zhang |Hu Li |Yong Fang |Kai Cao

What is this page? This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile. It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible.